The Senate confirmed billionaire private astronaut Jared Isaacman Wednesday in a 67-30 vote to serve as NASA administrator, months after President Donald Trump withdrew the same nomination during his public feud with Tesla and SpaceX CEO Elon Musk.

The confirmation places Isaacman, an investor in SpaceX and leader of two private spaceflight missions, at the helm of the nation’s space agency. Reuters reported that Isaacman becomes NASA’s 15th administrator and is known as an advocate of Mars missions.

Trump previously pulled Isaacman’s nomination in May, citing what he described at the time as ‘a thorough review of prior associations.’ 

Fox News Digital reported at the time that the decision was made amid escalating tensions between Trump and Musk, who had recently departed his role leading the Department of Government Efficiency (DOGE) and publicly criticized Trump’s ‘One Big, Beautiful Bill.’

Isaacman later suggested the timing of the withdrawal was no coincidence. 

Speaking on the ‘All-In Podcast,’ he said, ‘I don’t need to play dumb on this. I don’t think that the timing was much of a coincidence.’ He added that ‘there were some people that had some axes to grind, I guess, and I was a good, visible target,’ Fox News Digital previously reported.

The nomination was revisited in the fall as relations between Trump and Musk appeared to thaw. In October, NASA officials confirmed Isaacman was again under consideration after meetings with Transportation Secretary Sean Duffy, who was tasked with vetting candidates for the permanent NASA role at Trump’s direction.

Trump formally renominated Isaacman in November, praising him in a social media post.

‘Jared’s passion for Space, and his commitment to American Leadership in Space, make him ideally suited to lead NASA into a bold new Era,’ Trump wrote.

Fox News Digital has extensively reported on the broader Trump-Musk feud that surrounded the nomination’s earlier withdrawal. In May and June, the two men publicly exchanged harsh words over Trump’s ‘One Big, Beautiful Bill.’ 

Musk accused Trump of pushing a ‘disgusting abomination,’ while Trump said Musk had gone ‘CRAZY’ and was ‘wearing thin.’ 

Signs of reconciliation followed when Trump and Musk shook hands and spoke briefly at Charlie Kirk’s memorial, with Trump later saying, ‘We had a little conversation. We had a very good relationship, but it was nice that he came over.’ 

Musk also attended a White House dinner hosted by Trump and appeared at other administration events.

Trump later teased Musk publicly, telling an audience, ‘You’re so lucky I’m with you, Elon. I’ll tell you. Has he ever thanked me properly?’ 

Musk responded on X by saying, ‘I would like to thank President Trump for all he has done for America and the world.’

Axios reported Tuesday that Musk has begun financially backing Republican House and Senate candidates ahead of the 2026 midterms, showing warming relations after what the outlet described as a ‘messy breakup’ earlier this year. 

Politico similarly reported that Musk has said his relationship with Trump ‘went up in flames’ in June but has since been rebuilt.

Isaacman’s confirmation brings that arc to a close, cementing his leadership role at NASA. 

Isaacman previously commanded Inspiration4, the first all-civilian mission to orbit Earth, and later led the Polaris Dawn mission, both in partnership with SpaceX. 

The White House and representatives for Musk and Isaacman did not immediately respond to Fox News Digital’s requests for comment.

More than 200 House Democrats voted against a bill aimed at criminalizing transgender medical treatment for minors Wednesday evening.

The bill passed in a 216-211 vote that had some bipartisan crossover.

Three Democrats — Vicente Gonzalez, D-Texas; Don Davis, D-N.C.; and Henry Cuellar, D-Texas — voted with Republicans for the bill. 

Four Republicans — Mike Kennedy, R-Utah; Brian Fitzpatrick, R-Pa.; Gabe Evans, R-Colo.; and Mike Lawler, R-N.Y., voted against it.

It was widely opposed by most Democrats, however. Forty-five House Republicans signed on to formally back the legislation before the vote.

And while the majority of Republicans supported it on the House floor, it’s unclear if it will be taken up in the GOP-led Senate.

Transgender issues, particularly related to minors, have been one of the topics driving a wedge between moderate and progressive Democrats. But the severity of the bill’s language appears to have turned off a significant number of Democrats in the House.

The bill creates new federal crimes that carry up to 10 years in prison for doctors performing transgender-affirming surgeries on minors, while also making it a crime to prescribe puberty blockers.

Parents or guardians of children under 18 could also be held criminally liable if they consent to or otherwise facilitate transgender treatment for them.

‘This extreme bill puts the threat of prosecution between hundreds of thousands of families and their doctors and would put doctors behind bars for exercising their best medical judgment,’ said Mike Zamore, national director of policy & government affairs at the American Civil Liberties Union 

‘Passing this bill would be a grave escalation of an already severe effort to not only push transgender people out of public life but also allow the state to control our bodies and our lives further.’

Rep. Nancy Mace, R-S.C., who argued in favor of the bill on the House floor, said Wednesday, ‘It is obscene. It is disgusting. You’re seeing, in real time, Democrats wanting and defending grooming of children. And it is abhorrent.

‘There is a lie at the heart of the debate we’re having today that I have to correct. No child is born in the wrong body. There are only two sexes, male and female. There are no others.’

Senate Republicans inched closer to history Wednesday after blowing past yet another procedural obstacle on their way to confirming nearly 100 of President Donald Trump’s nominees.

As part of their mad dash from Washington ahead of the upcoming holiday recess, Senate Republicans advanced a tranche of 97 of Trump’s picks. The 53-47 party-line vote puts the GOP one step away from confirming the batch of nominees.

The final confirmation vote is expected Thursday, barring an agreement with Senate Democrats to speed up the process.

And if that vote is successful, which it is expected to be, Senate Republicans will have confirmed more of Trump’s picks than any other president in one year.

The current nominees package would place Trump at 415 total confirmed during the first year of his second term, which leapfrogs his total of 323 during his first term. It also blows past former President Joe Biden, who, at the same period at the end of his first year in office, had 365.

Senate Republicans have rapidly confirmed hundreds of Trump’s picks since changing the Senate’s rules for the confirmation process in September in a bid to smash through Senate Democrats’ blockade against advancing even the most low-level positions throughout the Trump administration.

The GOP went nuclear — the fourth time in the Senate’s history — to lower the threshold for certain picks to just a simple majority, rather than the typical, 60-vote filibuster.

That change has allowed Republicans to quickly move through sub-cabinet level positions at a brisk pace and to tee up Trump’s expected historic moment.

Among the list of nominees are former Rep. Anthony D’Esposito, R-N.Y., to serve as inspector general at the Department of Labor and two picks for the National Labor Relations Board, James Murphy and Scott Mayer, along with several others in nearly every federal agency.

Lawmakers also separately confirmed Trump’s choice to run NASA, billionaire Jared Isaacman, and his pick for a spot on the Nuclear Regulatory Commission, Douglas Weaver.

Isaacman’s confirmation sailed through on a bipartisan 67-30 vote but served as the second go-round for the upper chamber to ruminate on his ascension atop NASA.

Trump had nominated him to run the nation’s space agency in December 2024, but he was pulled earlier this year after a ‘thorough review of prior associations.’

But Isaacman was later nominated again in November for the same post, and Trump lauded his ‘passion for space, astronaut experience, and dedication to pushing the boundaries of exploration, unlocking the mysteries of the universe, and advancing the new space economy.’

FBI Deputy Director Dan Bongino is leaving the bureau in January after speculation rose this week concerning his departure.

‘I will be leaving my position with the FBI in January,’ Bongino wrote in an X post Wednesday. ‘I want to thank President [Donald] Trump, AG [Pam] Bondi, and Director [Kash] Patel for the opportunity to serve with purpose. Most importantly, I want to thank you, my fellow Americans, for the privilege to serve you. God bless America, and all those who defend Her.’

President Donald Trump hinted at the news on the tarmac at Joint Base Andrews earlier in the afternoon, saying, ‘Dan did a great job. I think he wants to go back to his show.’

Bongino, a former Secret Service agent, had no FBI experience before Trump tapped him to serve in the No. 2 position there. Prior to Bongino, the role had for more than a century been filled by someone who worked at the bureau, according to the FBI Agents Association. The position does not require Senate confirmation.

Fox News confirmed Andrew Bailey, co-deputy director, has been on the job since September and will stay on for now in the deputy role reporting to Patel.

The White House and the FBI did not immediately respond to Fox News Digital’s requests for comment.

This is a breaking story. Check back later for updates.

House Republicans passed a bill they say will lower healthcare costs for a broad swath of Americans by roughly 11%.

It’s a victory for Speaker Mike Johnson, R-La., who has been managing deep divisions within the House GOP on the topic of healthcare as insurance premiums are set to spike across the country in a matter of weeks.

One glaring issue that remains unresolved is Obamacare subsidies, which were enhanced during the COVID-19 pandemic but are set to expire at the end of this year.

The legislation passed 216 to 211. Just one Republican, Rep. Thomas Massie, R-Ky., voted against it along with all House Democrats.

The bill’s passage comes hours after a group of moderate Republicans joined a Democrat-led discharge petition to force a vote on extending the subsidies for another three years.

A discharge petition is a mechanism for overriding the will of House leaders to get a chamberwide vote on specific legislation, provided it has support from a majority of lawmakers. It sets up the legislation for a vote sometime in the new year.

Each of the four House Republicans made clear that backing Democrats’ bill was not their first choice, but they felt they were left with few options after Johnson made clear this week that there would not be a separate vote on extending the subsidies before the end of this year.

But the majority of House Republicans are against extending the subsidies, at least without significant reforms. Conservatives have argued the subsidies amount to throwing more money at a long-broken system that does little to tackle the actual cost of healthcare.

‘Obamacare has been an unmitigated disaster for 15 years, crushing families with high premiums and rampant fraud while enriching insurance companies. It’s time for conservatives to get serious about advancing policies that can become law and therefore actually reduce costs,’ Republican Study Committee Chairman August Pfluger, R-Texas, who called the House bill a ‘solid first step,’ told Fox News Digital.

Republicans who are for extending them have also conceded that reforms are needed, but have positioned a short-term extension as the best course of action to buy more time to work on an off-ramp.

The House GOP bill, the Lower Health Care Premiums for All Americans Act, includes provisions to codify association health plans, which allow small businesses and people who are self-employed to band together to purchase healthcare coverage plans, giving them access to greater bargaining power.

Republicans also plan to appropriate funding for cost-sharing reductions beginning in 2027, which are designed to lower out-of-pocket medical costs in the individual healthcare market. House GOP leadership aides said it would bring down the cost of premiums by 12%.

New transparency requirements for pharmacy benefit managers (PBMs) are also in the legislation, aimed at forcing PBMs to be more upfront about costs to employers.

PBMs are third parties that act as intermediaries between pharmaceutical companies and those responsible for insurance coverage, often responsible for administrative tasks and negotiating drug prices.

PBMs have also been the subject of bipartisan ire in Congress, with both Republicans and Democrats accusing them of being part of a broken system to inflate health costs.

The nonpartisan Congressional Budget Office (CBO) estimated that enacting the bill would reduce the federal deficit by $35.6 billion for a 10-year period through 2035.

If the bill became law, it would also decrease the number of people with health insurance by an average of 100,000 per year between 2027-2035 and lower gross benchmark premium costs by an average 11% through 2035, CBO said.

However, it’s not immediately clear whether it will be taken up by the Senate.

Republicans in the upper chamber failed to advance their own healthcare plan last week after also rejecting Democrats’ plan to extend the Obamacare subsidies.